Prevalence of Subclinical Hypothyroidism and Its Association with Noninvasive Fibrosis Scores in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
OSMANGAZİ JOURNAL OF MEDICINE · 09.06.2026 · 48 (4) · 646-653
DOI: 10.20515/otd.1883806 ↗Kurz gefasst
Fachartikel in der Zeitschrift OSMANGAZİ JOURNAL OF MEDICINE, online erschienen am 09.06.2026. Verfasst von Aysun Şeker. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely related to obesity, insulin resistance, and diabetes mellitus. Thyroid hormones play a key role in lipid and glucose metabolism, and subclinical hypothyroidism has been suggested to contribute to metabolic disturbances. This study aimed to determine the prevalence of subclinical hypothyroidism in patients with MASLD and evaluate its association with noninvasive fibrosis scores. This retrospective cross-sectional study included 200 adult patients diagnosed with MASLD. Patients were classified as having subclinical hypothyroidism or euthyroid status based on thyroid function tests. Demographic characteristics, metabolic parameters, and laboratory findings were recorded. Fibrosis risk was assessed using the Fibrosis-4 (FIB-4) index and the non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS). Group comparisons, correlation analyses, and multivariable logistic regression were performed. The mean age of the study population was 54.2 ± 9.7 years, 58% of patients were female, and the prevalence of subclinical hypothyroidism was 18%. No significant differences were observed between subclinical hypothyroid and euthyroid groups in FIB-4 or NFS values. A weak but statistically significant correlation was observed between TSH levels and the FIB-4 index (r = 0.15, p = 0.034), whereas no significant correlation was found with NFS. In multivariable analysis adjusted for age, sex, body mass index, diabetes mellitus, homeostasis model assessment of insulin resistance (HOMA-IR), and triglyceride-to-high-density lipoprotein (HDL) cholesterol ratio, subclinical hypothyroidism was not independently associated with advanced fibrosis risk. These findings indicate metabolic factors remain the primary determinants of fibrosis risk.
Zitieren
APA
Şeker, A. (2026). Prevalence of Subclinical Hypothyroidism and Its Association with Noninvasive Fibrosis Scores in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. OSMANGAZİ JOURNAL OF MEDICINE, 48(4), 646-653. https://doi.org/10.20515/otd.1883806
Vancouver
Şeker A. Prevalence of Subclinical Hypothyroidism and Its Association with Noninvasive Fibrosis Scores in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. OSMANGAZİ JOURNAL OF MEDICINE. 2026;48(4):646-653. doi:10.20515/otd.1883806
BibTeX
@article{eker2026,
author = {Şeker, Aysun},
title = {Prevalence of Subclinical Hypothyroidism and Its Association with Noninvasive Fibrosis Scores in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease},
journal = {OSMANGAZİ JOURNAL OF MEDICINE},
year = {2026},
volume = {48},
number = {4},
pages = {646--653},
doi = {10.20515/otd.1883806}
}
EUVIMED